- audits of the public procurement process in DG Presidency, DG Infrastructure and Logistics and DG Finance as well as follow-up of the central actions from Internal Audit Report No 05/02 adopted on 31 March 2006;

audits of the public procurement process in DG Presidency, DG Infrastructure and Logistics and DG Finance as well as follow-up of the central actions from Internal Audit Report No 05/02 adopted on 31 March 2006;

Ladies and gentlemen, if we do not manufacture more cars, more planes, more ships, more trains, more satellites, more medicines, more nuclear power stations, we will be ruined!

This report not only endorses the Commission’s proposed changes but also enhances them in some areas, including: strengthening the role of the Pharmacovigilance Risk Assessment Advisory Committee, which must have the power to recommend action to the Committee for Medicinal Products for Human Use; strengthening the role of healthcare professionals in the sense of voluntarily reporting adverse drug reactions; strengthening the role of patients in directly reporting adverse reactions; requiring that all adverse drug reactions (and not just serious ones) are reported to the Eudravigilance database by competent authorities and companies, w ...[+++]hich means that information on all adverse drug reactions will, for the first time, be centralised in one place in the EU; and requiring patient information leaflets that give a clearer indication of the main features of the drugs.

With regard to the priority thematic areas of research and, in particular, the measures envisaged in the field of genomics and biotechnology for health, we would stress the need to identify two specific objectives for the broad strategy to combat the three infectious diseases linked to poverty (AIDS, malaria and tuberculosis) and hence reduce the research deficit, on the part of private pharmaceutical industries, in the field of generic drugs, and to contain the cost patenting drugs inaccessible to the inhabitants of the least developed countries. A review of patent legislation is therefore considered to be a priority for ...[+++]Community action in the sector.

For our part, we are firmly convinced, and this will be a focus of commitment for the Official Opposition, that there are ways to put an end to that poverty.